| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7385eed14627b7e59a9e336683f7a0f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fa4c37b4aacb317ee027a1a729de4ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f88adce684feb13cbff92806e56e5220
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a2b593051def7ecedaf5d37fab35be9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43ee2e694e435c2ec6638ef4b17d70a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe8bfeb45747fe205b8795da57ee160
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5007828ad4d5cc8ae4a6de0b8ea5834 |
| publicationDate |
2008-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008038944-A1 |
| titleOfInvention |
Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof |
| abstract |
The present invention relates to a nanoparticle composition comprising a camptothecin derivative, solid polyethyleneglycol and an anti-associative agent, and the process for preparing the same. Specifically, the present invention provides a composition comprising a nanoparticle of the camptothecin derivative, which is prepared by solid-dispersing the poorly water soluble camptothecin derivative in polyethyleneglycol and dissolving the solid dispersions in an aqueous solution containing an anti-associative agent. The composition of the present invention stabilizes the camptothecin derivative lactone form in body fluid for effective anticancer activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012526890-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010015688-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100946275-B1 |
| priorityDate |
2006-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |